STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1076 by analyst upside · 2026-08-12
AVR
Anteris Technologies Global Corp.
Healthcare · Market Cap $893M · P/E 0x
ANALYST PRICE TARGET
+67.2%
implied upside to consensus target
Current Price $9.17
Consensus Target $15.33
Bull Target $16.0
Bear Target $15.0
Analysts Covering 3
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
3
Hold
0
Sell
0
52-Week Low $3.17
52-Week High $11.05
YTD Return +86.4%
FUNDAMENTALS
Market Cap $893M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.22
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $2M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $3.17
52-Week High $11.05
Current Price $9.17
Bear Target $15.0
Bull Target $16.0
● Now $9.17 ● Target $15.33
TRADING DATA
Avg Volume 1.3M
YTD Return +86.4%
Analyst Count 3
Consensus Buy
Upside to Target +67.2%
Last Updated 2026-08-12

ANALYST SUMMARY

Anteris Technologies Global Corp. (AVR) is currently trading at $9.17 with a Wall Street consensus price target of $15.33, implying potential upside of 67.2% over the next 12 months. 3 analysts currently cover AVR, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $16.0, while the most cautious has a target of $15.0.

AVR operates in the Healthcare sector with a market capitalisation of $893M. The stock is up 86.4% year-to-date and is currently trading near the upper end of its 52-week range of $3.17 – $11.05.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for AVR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Overweight → Overweight 2026-05-15 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2026-03-27 40% win rate (10 calls)
Wells Fargo ● Initiated
Overweight 2026-03-11 Building track record
Lake Street ● Initiated
Buy 2025-01-08 27% win rate (11 calls)
TD Cowen ● Initiated
Buy 2025-01-07 Building track record
Cantor Fitzgerald ● Initiated
Overweight 2025-01-07 40% win rate (10 calls)
Barclays ● Initiated
Overweight 2025-01-07 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
66
out of 100
Coverage depth
11/30
Consensus clarity
28/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →